|
|
|
|
| LEADER |
00000cam a2200000 7i4500 |
| 001 |
0000059537 |
| 005 |
20100216.0 |
| 008 |
081023s2007 pau eng |
| 020 |
|
|
|a 0781763835
|
| 020 |
|
|
|a 9780781763837
|
| 050 |
0 |
0 |
|a RA969
|b .H64 2007
|
| 060 |
1 |
0 |
|a WX 167
|b B4705 2007
|
| 090 |
0 |
0 |
|a WX 167
|b B4705 2007
|
| 245 |
0 |
0 |
|a Bennett & Brachman's hospital infections
|c editor, William R. Jarvis
|
| 246 |
3 |
|
|a Bennett and Brachman's hospital infections
|
| 246 |
3 |
0 |
|a Hospital infections
|
| 250 |
|
|
|a 5th ed
|
| 260 |
|
|
|a Philadelphia :
|b Wolters Kluwer Health/Lippincott Williams & Wilkins ,
|c c2007
|
| 505 |
0 |
|
|a 1. Epidemiology of healthcare-associated infections -- 2. The healthcare epidemiologist -- 3. Hand hygiene -- 4. Personnel health services -- 5. The development of infection surveillance and control programs -- 6. Surveillance of healthcare-associated infections -- 7. Investigating endemic and epidemic healthcare-associated infections -- 8. Epidemiological methods for investigating infections in the healthcare setting -- 9. Use of computerized systems in healthcare epidemiology -- 10. The role of the laboratory in control of healthcare-associated infections -- 11. The practice of epidemiology in community hospitals -- 12. The role of professional and regulatory organizations in infection control -- 13. Antimicrobial stewardship: programmatic efforts to optimize antimicrobial use -- 14. Multiply drug-resistant pathogens: epidemiology and control -- 15. Molecular biology of resistance -- 16. Economic evaluation of healthcare-associated infections and infection control interventions -- 17. Legal aspects of healthcare-associated infections -- 18. Infection control: a global view -- 19. The inanimate environment -- 20. Sterilization and disinfection -- 21. Foodborne disease prevention in healthcare facilities -- 22. Clinical laboratory-acquired infections -- 23. Dialysis-associated complications and their control -- 24A. The intensive care unit: part A. HAI epidemiology, risk factors, surveillance, engineering and administrative infection control practices, and impact -- 24B. The intensive care unit: part B. antibiotic resistance and prevention of CVC-BSIs, catheter-associated urinary tract infections and C. difficile -- 25. The newborn nursery and the neonatal intensive care unit -- 26. The operating room -- 27. Ambulatory care setting -- 28. Infections in long-term care facilities -- 29. Incidence and nature of endemic and epidemic healthcare-associated infections -- 30. Urinary tract infections -- 31. Hospital-acquired pneumonia -- 32. Tuberculosis -- 33. Infectious gastroenteritis -- 34. Central nervous system infections -- 35. Surgical site infections -- 36. Infections of burn wounds -- 37. Infections due to infusion therapy -- 38. Infections of implantable cardiac and vascular devices -- 39. Infections in skeletal prostheses -- 40. The importance of infection control in controlling antimicrobial-resistant pathogens -- 41. Healthcare-associated respiratory viral infections -- 42. Blood borne pathogen prevention -- 43. Healthcare-associated fungal infections -- 44. Infection in transplant recipients -- 45. Miscellaneous procedure-related infections -- 46. Public reporting of healthcare-associated infection rates -- 47. Patient safety
|
| 650 |
|
0 |
|a Nosocomial infections
|x Prevention
|
| 650 |
1 |
2 |
|a Cross Infection
|x prevention & control
|
| 650 |
2 |
2 |
|a Cross Infection
|x etiology
|
| 700 |
1 |
|
|a Jarvis, William R. [
|q (William Robert)] ,
|d 1948- ,
|e author
|
| 999 |
|
|
|a 1000120381
|b Book
|c OPEN SHELF (30 DAYS)
|e Medical Campus
|